Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Vice President of Quality | February 01, 2018 | March 22, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date February 01, 2018 · Filed March 22, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.60 · Expires 2028-02-01 | Direct | 70,000 |
Reported balance
After 2018-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-02-01 · Grant · Acquired 70,000 · Balance 70,000 F1: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2018 Filed Mar 22, 2018 18:24 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001437749-18-005231 · rdgdoc.xml · derivative · entry 1 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common stock · 70,000 shares Expires 2028-02-01 F1 · derivative.exercise_date: The option vests and becomes exercisable as to 1/48th of the shares on March 1, 2018 and each monthly anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 237,250 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001437749-17-016912 · rdgdoc.xml · derivative · entry 4 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 798,462 Underlying: Common Stock · 237,250 shares Expires 2026-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 585,875 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001437749-17-016912 · rdgdoc.xml · derivative · entry 3 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,399 Underlying: Common Stock · 585,875 shares Expires 2026-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on December 1, 2016 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 237,250 | $0.15 | $35,587.50 |
DisclosureSEC source: 0001437749-17-016912 · rdgdoc.xml · nonDerivative · entry 2 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:03 UTC | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 585,875 | $0.15 | $87,881.25 |
DisclosureSEC source: 0001437749-17-016912 · rdgdoc.xml · nonDerivative · entry 1 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2017 Filed Feb 5, 2018 11:25 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 232,842 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001437749-18-001603 · rdgdoc.xml · derivative · entry 4 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 802,870 Underlying: Common Stock · 232,842 shares Expires 2026-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The Reporting Person incorrectly listed the number of shares exercised under the employee stock option and is filing this Form 4 to correct the amount acquired. F4 · derivative.exercise_date: One-forty-eighth of the shares subject to the option vest on November 24, 2016 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| October 03, 2017 Filed Feb 5, 2018 11:25 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 574,749 | $0.00 Strike: $0.15 | $0.00 |
DisclosureSEC source: 0001437749-18-001603 · rdgdoc.xml · derivative · entry 3 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,525 Underlying: Common Stock · 574,749 shares Expires 2026-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The Reporting Person incorrectly listed the number of shares exercised under the employee stock option and is filing this Form 4 to correct the amount acquired. F3 · derivative.exercise_date: One-fourth of the shares subject to the option vest on December 1, 2016 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| October 03, 2017 Filed Feb 5, 2018 11:25 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 232,842 | $0.15 | $34,926.30 |
DisclosureSEC source: 0001437749-18-001603 · rdgdoc.xml · nonDerivative · entry 2 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 807,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person incorrectly listed the number of shares acquired via option exercise and is filing this Form 4 to correct the amount acquired. Read SEC document |
| October 03, 2017 Filed Feb 5, 2018 11:25 UTC Amendment | BioCardia, Inc. BCDA · Entity 7752 | Exercise / conversionCommon Stock | 574,749 | $0.15 | $86,212.35 |
DisclosureSEC source: 0001437749-18-001603 · rdgdoc.xml · nonDerivative · entry 1 Allen Richard T · CIK 0001686153 · Vice President of Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Reporting Person incorrectly listed the number of shares acquired via option exercise and is filing this Form 4 to correct the amount acquired. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.